TCSAM
NDRM

Tyrus Capital S.A.M.’s NeuroDerm Ltd. Ordinary Shares NDRM Stock Holding History

Tyrus Capital S.A.M.’s Portfolio NDRM Stock Details NDRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-185,300
Closed -$7.21M – 35
2017
Q3 		$7.21M Buy
+185,300
New +$6.82M 0.56% 16

Other funds holding NDRM

VOAM
Vertex One Asset Management Vancouver, British Columbia, Canada $434M AUM 37.82% 1-Year Est. Return
OTC
Opera Trading Capital Paris, France $419M AUM 0.58% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
FWM
Focused Wealth Management Newburgh, New York $964M AUM 18.71% 1-Year Est. Return

Tyrus Capital S.A.M.'s NDRM Position: Q4 2017 in Review

Tyrus Capital S.A.M. sold out of NeuroDerm Ltd. Ordinary Shares (NDRM) in Q4 2017, closing a stake of 185,300 shares — an estimated $7.21M sold.

Tyrus Capital S.A.M. first reported a position in NDRM in Q3 2017 and held it in 1 quarter. The position peaked at $7.21M in Q3 2017. 5 funds tracked by Wall St. Rank hold NDRM as of Q4 2017.

  • Tyrus Capital S.A.M. reported no remaining NeuroDerm Ltd. Ordinary Shares position as of Q4 2017 after selling out during the quarter.
  • Tyrus Capital S.A.M. sold 185,300 NeuroDerm Ltd. Ordinary Shares shares in Q4 2017, an estimated $7.21M.
  • Tyrus Capital S.A.M. first reported a position in NeuroDerm Ltd. Ordinary Shares in Q3 2017 and held it in 1 quarter.
  • Tyrus Capital S.A.M.'s NeuroDerm Ltd. Ordinary Shares position peaked at $7.21M in Q3 2017.
  • 5 funds tracked by Wall St. Rank held NeuroDerm Ltd. Ordinary Shares as of Q4 2017.

Based on Tyrus Capital S.A.M.'s 13F filing for Q4 2017, filed 14 Feb 2018.